Search

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.

… Monday, January 6, 2025 Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors — a type of immunotherapy — using only routine blood tests and clinical data. The artificial intelligence–based

Learn about how The Society of Memorial Sloan Kettering is supporting precision medicine at MSK Kids.

… Wednesday, April 1, 2020 On February 5, The Society of Memorial Sloan Kettering hosted its seventh annual Winter Lunch to support its Precision Medicine for MSK Kids initiative. More than 275 guests attended this year’s event, which was sponsored by Net-a-Porter for the fifth consecutive year, at the

Mutations in a gene called FOXA1 are responsible for a distinct class of prostate cancer tumors, MSK researchers have found.

… Wednesday, June 26, 2019 Summary Researchers at Memorial Sloan Kettering have identified molecular changes in a protein that promote a distinct type of prostate cancer. The findings suggest that this protein could be a good drug target for men with this form of the disease. Prostate cancer is not one

Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.

… Monday, September 12, 2022 Promising new drugs have begun to transform the treatment of bladder (or urothelial) cancer, the sixth most common form of the disease in the U.S., and the fourth most common in men. In particular, two drug classes, antibody-drug conjugates (ADCs) and checkpoint inhibitors,

Learn the most frequently asked questions about immunotherapy, a form of cancer treatment that uses the body's own immune system to overpower cancer cells. Learn who it can help, how it works, and how experts at MSK are finding ways to make it benefit more people, including new combinations with other cancer treatments like chemotherapy, surgery, radiation and more.

… Tuesday, November 7, 2023 Immunotherapy is one of the most promising approaches to cancer treatment . Unlike other forms of cancer treatment, in which drugs or radiation target cancer cells directly, immunotherapy targets your immune system, boosting its innate power to fight the cancer. But how does

After receiving a stem cell transplant for multiple myeloma, John Savarese developed graft-versus-host disease (GVHD). MSK’s specialized GVHD clinic got him back to feeling like himself again.

… Thursday, April 7, 2022 When John Savarese went to see Memorial Sloan Kettering Cancer Center (MSK) hematologic oncologist Doris Ponce for the first time in the fall of 2021, he was not well. “I felt like I was 100 years old,” says the 63-year-old retired air traffic controller and Brooklyn native. “

MSK experts acted quickly to understand the possible effects of COVID-19 on cancer patients and drew on vast experience to explore new treatments.

… Thursday, October 1, 2020 In March 2020, medical oncologist Santosha Vardhana was faced with a new challenge: Many of his patients with lymphoma were becoming infected with the COVID-19 virus. As he saw more cases, Dr. Vardhana noticed a troubling pattern begin to emerge. Patients were managing well

Lab mice who had lactose removed from their diets had a decreased risk of infection with the Enterococcus bacterium.

… Friday, November 29, 2019 Summary An international team led by scientists from MSK has shown for the first time that foods containing lactose, a sugar that’s naturally found in milk and dairy products, help Enterococcus thrive in the gut, at least in mice. Infections with the Enterococcus bacterium are

Learn how 4-year-old Sienna, her family, and the people of MSK Kids inspire each other to continue improving treatments for all children with cancer.

… Thursday, September 4, 2025 When 4-year-old Sienna skips into MSK Kids wearing rainbows and a big smile, the whole space lights up.   “Despite facing this very serious disease and going through difficult treatment, Sienna is always so happy and upbeat,” says her doctor, pediatric hematologist-oncologist

Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering.

… Thursday, October 14, 2021 Imagine you’re about to go on a cross-country trip, stopping at spots along the way to admire local attractions. You’d probably want to have a road atlas handy, containing maps at different scales, covering both the major highways and the roads of smaller cities and towns —